CenterBook Partners’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
CenterBook Partners's ASND Position: Q3 2026 in Review
CenterBook Partners increased its Ascendis Pharma (ASND) stake by 31% in Q3 2026, buying an estimated $249K and bringing the position to 4,108 shares worth $936K. The position accounts for 0.04% of the portfolio, ranked #456.
CenterBook Partners first reported a position in ASND in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.07M in Q2 2023. 346 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- CenterBook Partners held 4,108 shares of Ascendis Pharma worth $936K as of Q3 2026.
- CenterBook Partners bought 982 Ascendis Pharma shares in Q3 2026, an estimated $249K.
- Ascendis Pharma made up 0.04% of CenterBook Partners's portfolio in Q3 2026, its #456 holding.
- CenterBook Partners first reported a position in Ascendis Pharma in Q2 2022 and has held it in 11 quarters since.
- CenterBook Partners's Ascendis Pharma position peaked at $2.07M in Q2 2023.
- 346 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.